Celerion

About

Early-phase clinical CRO specializing in Phase I-III trials including first-in-human, SAD/MAD, DDI, TQT studies, bioequivalence, and ADME/excretion studies. Operates in-house pharmacy and specialized clinical research units for complex early-phase trials.

Services